Molecular Partners AG ADR (MOLN) Stock Forecast & Price Target
Molecular Partners AG ADR · NASDAQ
$4.35+0.00 (+0.00%)
15-min delayed · Sep 4, 9:45 AM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Molecular Partners AG ADR, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $3.75 to $13.00 (about 3.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $8.38 sits 93% above the current $4.35. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.22 next quarter toward $-0.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Molecular Partners AG ADR.
As of Sep, 1 of 2 firms rate MOLN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MOLN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.22
Range $-0.22 – $-0.22 · 1 analysts · -39% YoY
Next period, 1 analysts expect Molecular Partners AG ADR to earn $-0.22 a share (range $-0.22 – $-0.22), versus $-0.36 a year earlier. Full-year consensus is $-1.11, growing to $-0.14 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $5.6M, rising to $30.7M next year.
Top analysts covering Molecular Partners AG ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MOLN.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #199
Buy
$13.00+198.9% to target
Overall win rate
41%
+ Follow
#2
RV
Richard Vosser
JP Morgan
Hold
$3.75-13.8% to target
Coverage
—
+ Follow
#3
Jonathan Chang
Leerink Partners
Buy
No targeton MOLN
Coverage
—
+ Follow
#4
WM
William Maughan
Clear Street
Buy
$8.00+83.9% to target
Coverage
—
+ Follow
MOLN stock forecast FAQ
What is MOLN's average 12-month price target?+
The 2 analysts with a live target average $8.38 for Molecular Partners AG ADR over the next 12 months, ranging from a $13.00 high to a $3.75 low.
Is MOLN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MOLN?+
The Street-high target is $13.00 (HC Wainwright & Co.), and the Street-low is $3.75 (JP Morgan). The average of all 2 active targets is $8.38.
How many Wall Street analysts cover MOLN?+
2 analysts have an active rating on Molecular Partners AG ADR, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering MOLN?+
Among analysts who currently cover MOLN, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #199). Their current call is Buy with a $13.00 target.
What is Molecular Partners AG ADR's projected EPS for next quarter?+
The consensus estimate is $-0.22 per share (range $-0.22 – $-0.22) across 1 analysts. Full-year EPS is projected at $-1.11, rising to $-0.14 the following year.
How much revenue is Molecular Partners AG ADR expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $5.6M, growing to $30.7M next year.
Have analysts been upgrading or downgrading MOLN lately?+
As of Sep, 1 of 2 firms rate MOLN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MOLN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
